Contents

Current Pharmaceutical Design, Volume 22 - Number 8

Editorial

Editorial (Thematic Issue: The Kynurenine and Melatonergic Pathways in Psychiatric and CNS Disorders)

, 22(8): 947 - 948

George Anderson


DOI: 10.2174/1381612822999160104143932




Depression, Serotonin and Tryptophan

, 22(8): 949 - 954

Liliana Dell’Osso, Claudia Carmassi, Federico Mucci and Donatella Marazziti


DOI: 10.2174/1381612822666151214104826




Cognition and Emotions in Recurrent Depressive Disorders - The Role of Inflammation and the Kynurenine Pathway

, 22(8): 955 - 962

Monika Talarowska and Piotr Galecki


DOI: 10.2174/1381612822666151230110738




The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders

, 22(8): 963 - 977

Gerwyn Morris, André F. Carvalho, George Anderson, Piotr Galecki and Michael Maes


DOI: 10.2174/1381612822666151215102420




Melatonin in Pregnancy: Effects on Brain Development and CNS Programming Disorders

, 22(8): 978 - 986

Lucas Sagrillo-Fagundes, Eugenia Maria Assuncao Salustiano, Philippe Wong Yen, Ahmed Soliman and Cathy Vaillancourt


DOI: 10.2174/1381612822666151214104624




Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways

, 22(8): 987 - 1012

George Anderson, Aude Jacob, Frank Bellivier and Pierre Alexis Geoffroy


DOI: 10.2174/1381612822666151214105314




Tryptophan Catabolites and Migraine

, 22(8): 1013 - 1021

Zsuzsanna Bohár, Árpád Párdutz and László Vécsei


DOI: 10.2174/1381612822666151214105439




Melatonin Attenuates Methamphetamine-Induced Neurotoxicity

, 22(8): 1022 - 1032

Pawaris Wongprayoon and Piyarat Govitrapong


DOI: 10.2174/1381612822666151214125657




Glioma: Tryptophan Catabolite and Melatoninergic Pathways Link microRNA, 14-3- 3, Chromosome 4q35, Epigenetic Processes and other Glioma Biochemical Changes

, 22(8): 1033 - 1048

Timothy V. Beischlag, George Anderson and Gianluigi Mazzoccoli


DOI: 10.2174/1381612822666151214104941




Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression

, 22(8): 1049 - 1059

Jens O. Watzlawik, Bharath Wootla and Moses Rodriguez


DOI: 10.2174/1381612822666151215095940




The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia

, 22(8): 1060 - 1073

María Isabel Cuartero, Juan de la Parra, Alicia García-Culebras, Iván Ballesteros, Ignacio Lizasoain and María Ángeles Moro


DOI: 10.2174/1381612822666151214125950




Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer's Disease

, 22(8): 1074 - 1085

Michael Maes and George Anderson


DOI: 10.2174/1381612822666151214125804




Melatonin and Synthetic Melatoninergic Agonists in Psychiatric and Age-associated Disorders: Successful and Unsuccessful Approaches

, 22(8): 1086 - 1101

Rüdiger Hardeland


DOI: 10.2174/1381612822666151214125543




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science